Two years of audited financials and likely consolidated as GSCM has said they would be looking to up-list to NASDAQ. (that is one of the requirements they would have to meet as they already meet revenue and with 35 stem cell centers, likely assets as well).
Those are some serious 10-k's and will likely take most if not all of the 90 days the company has projected.
In the meantime, no RS is possible and once the definitive is done the reality of just how undervalued this is will put this multi penny in short order.
News 
Market Data 
Discover 
